According to Medicinenet, the FDA has approved many monoclonal antibody drugs, and this week I will be discussing belimumab also known as Benlysta. What’s a monoclonal antibody drug you may ask? Well, our bodies produce antibodies upon infection of viruses, bacteria, parasites, or other harmful substances that evoke an immune response to fight off these pathogens. Mednet explains that scientists can also create antibodies that fight proteins that attack normal tissues in those who have autoimmune disorders. These antibodies are synthetically made to mimic those of the immune system to attack antigens which could be key for cancer treatments and for autoimmune diseases.
In the FDA’s approved list of monoclonal antibody drugs, belimumab caught my attention because this drug helps stop B cell activity involved in patients with systemic lupus erythematosus (SLE), an autoimmune disease. In SLE, the host’s B cells attack self-tissues and evoke an immune response. The goal of belimumab is to stop B cells by inhibiting BLys protein in B cells which are necessary for survival of the B cells, so patients experience less activity of SLE due to fewer antibodies produced by B cells that would attack self-tissues. Since this drug is negatively impacting the B cells of the acquired immune response, it is possible that this drug will cause other infections and even increase the risk of cancer. Also, patients taking belimumab should not be administered live vaccines since the acquired immune response is suppressed by belimumab. Below, I have listed all the possible side effects of belimumab. SLE effects a patient’s heart, skin, kidneys, lungs, and brain with symptoms including rash, fever, chest pain, hair loss, joint pain, fatigue and sensitivity to light. As you can see in the list of side effects, itching, rash, leg or arm pain, and insomnia are all possible effects of the drug. In SLE, patients can also have these symptoms, and this drug is supposed to treat these problems, but it may cause worsened symptoms.
- nausea,
- diarrhea,
- vomiting,
- stomach pain,
- fever,
- stuffy or runny nose,
- cough (bronchitis),
- insomnia,
- leg or arm pain,
- migraine, and sore throat.
- allergic or infusion-related reactions such as itching; swelling of the face,
- lips,
- tongue, mouth, or throat as well as
- difficulty breathing,
- low blood pressure,
- dizziness,
- fainting,
- rash,
- redness, or
- swelling of the skin.
I think that the creation of monoclonal antibody drugs could be a great way to stop autoimmune diseases and cancer. However, when looking at the side effects of the drug and the symptoms of SLE, I am leaning on the side of caution because this drug seems to treat symptoms of LSE, but also bring about new side effects and problems for the patient. I think with further research, scientists could be able to limit these side effects and create more beneficial outcomes for patients. I think it is one step closer to finding a cure for cancer or autoimmune diseases in which patients self-tissues attack and cause immune response. This is my last blog post and I have had so much fun getting to share my thoughts and hopefully inform some readers about the world of microbiology. XOXO Carley
